---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-085360"
form_type: "8-K"
ticker: "PASG"
cik: "0001787297"
company_name: "Passage BIO, Inc."
filed_at: "2024-08-02T23:59:59+00:00"
generated_at: "2026-05-31T13:29:37.331762+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Passage Bio receives Nasdaq delisting notice for bid price below $1.00

## Summary
- Notice received Aug 1, 2024; closing bid price below $1.00 for 30 consecutive days.
- 180-day compliance period until Jan 28, 2025 to regain minimum $1.00 bid for 10 days.
- If not cured, may seek transfer to Nasdaq Capital Market with additional 180-day grace period.
- No decisions on response yet; cannot assure regaining compliance.

## SEC filing metadata
- accession: 0001104659-24-085360
- form_type: 8-K
- ticker: PASG
- cik: 0001787297
- company_name: Passage BIO, Inc.
- filed_at: 2024-08-02T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1787297/000110465924085360/0001104659-24-085360-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1787297/000110465924085360/tm2420762d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-085360
- JSON: https://secwatch.observer/filing/0001104659-24-085360.json
- Plain text: https://secwatch.observer/filing/0001104659-24-085360.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.